Kopran Ltd share price logo

Kopran Share Price

(KOPRAN)

Check the latest share price of Kopran, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.

₹196.36

2.35%

as on 04:01PM, 29 Apr 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Kopran Performance

Get real-time share price information, day’s high and low, historical returns and market stats.

  • Day's Low

    Day's High

    ₹194.11
    Day's Price Range
    ₹204.89
  • 52 Week's Low

    52 Week's High

    ₹155
    52-Week Price Range
    ₹369.7
1 Month Return+ 19.89 %
3 Month Return-4.04 %
1 Year Return-26.82 %
Previous Close₹201.09
Open₹202.70
Volume1.82L
Upper Circuit-
Lower Circuit-
Market Cap₹917.81Cr

Kopran Fundamentals & Key Indicators

Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.

Market Cap

₹917.81 Cr

Return on Equity (ROE)

3.75

Return on capital employed (ROCE)

5.57

P/B Ratio

3.58

Dividend Yield

1.07

EPS (TTM)

12.66

Sector

Pharmaceuticals

How to invest in Kopran

Investing in Kopran is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Kopran or KOPRAN on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Kopran or start an SIP based on the market price on each investment date.

You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Kopran with just a few clicks!

Kopran Valuation

Track how the P/E of Kopran has moved over time to understand valuation trends.

Kopran in the last 5 years

  • Overview

  • Trends

Lowest (3.00x)

March 24, 2020

Today (39.60x)

December 15, 2023

Industry (58.33x)

December 15, 2023

Highest (53.33x)

September 5, 2023

LowHigh

Today’s Price to Earnings Ratio: 39.60x

Kopran Financials

Get the annual and quarterly financial summary of Kopran, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ'2 23Q'3 23Q'4 23Q'1 24Q'2 24
Revenue₹117.00Cr (-)₹152.59Cr (↑30.42%)₹158.92Cr (↑4.15%)₹186.08Cr (↑17.09%)₹139.44Cr (↓25.06%)
Net Income₹2.77Cr (-)₹13.77Cr (↑397.11%)₹15.79Cr (↑14.67%)₹18.62Cr (↑17.92%)₹11.10Cr (↓40.39%)
Net Profit Margin2.37% (-)9.02% (↑280.59%)9.94% (↑10.20%)10.01% (↑0.70%)7.96% (↓20.48%)
Value in ₹ crore
Details2019202020212022
Total Assets₹322.80Cr (-)₹331.73Cr (↑2.77%)₹326.35Cr (↓1.62%)₹465.44Cr (↑42.62%)
Total Liabilities₹98.78Cr (-)₹102.06Cr (↑3.32%)₹79.50Cr (↓22.10%)₹86.72Cr (↑9.08%)
Value in ₹ crore
Details20182019202020212022
Operating Cash Flow₹12.50Cr (-)₹11.84Cr (↓5.28%)₹9.97Cr (↓15.79%)₹48.77Cr (↑389.17%)-₹37.81Cr (↓177.53%)

Kopran Index Inclusions

BSE Healthcare

₹42,555.65

0 (0%)

BSE Small-Cap

₹48,193.46

0 (0%)

S&P BSE AllCap

₹10,471.31

0 (0%)

Kopran Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Kopran.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
44.3%
0.00
Foreign Institutions
0.41%
0.00
Mutual Funds
0%
0.00
Retail Investors
55.15%
0.00
Others
0.14%
0.00

Kopran vs Peers

Compare market cap, revenue, PE, and other key metrics of Kopran with its industry peers.

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹917.81 Cr113.16%0.55NANA
NA₹81.01 Cr41.61%0.64NANA
NA₹12.19 Cr-9.37%0.50NANA
BUY₹408.83 Cr182.55%0.55NANA
NA₹3,197.59 Cr34.5%0.57NANA

Kopran News & Key Events

Latest news and events at one place to help you take investing decisions in Kopran.

  • Kopran Stock Rises After Successful USFDA Inspection - 28 Apr, 2025

    Kopran's stock surged 4.39% following a successful USFDA inspection at its subsidiary's API facility, which concluded without any observations. The company reported a 34.14% decline in net profit for Q3 December 2024.
  • Kopran Stake Increase Amid Stock Decline - 26 Apr, 2025

    Kela increased his stake in Kopran to 1.46%, up from 1.04%. However, the stock has faced significant declines, falling 11% year-to-date and 25% over the past year.
  • Kopran Ltd Shows Strong Growth and Upcoming Merger - 16 Apr, 2025

    Kopran Ltd has demonstrated significant sales and profit growth, with a 578% increase in share price since April 2020. The company plans to merge with Kopran Laboratories Limited, enhancing its market position.
  • Madhuri Kela Increases Stake in Kopran Amid Challenges - 10 Apr, 2025

    Madhuri Kela raised her stake in Kopran Ltd to 1.46%, signaling confidence despite the stock's 37% decline over the past year. The company is merging with Kopran Laboratories to optimize operations. Recent performance shows a 4% gain in March 2025, but the stock remains below its 52-week peak.

Insights on Kopran Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, KOPRAN stock has moved up by 6.5%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 142.06 Cr → 166.41 Cr (in ₹), with an average increase of 7.6% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 7.38 Cr → 10.4 Cr (in ₹), with an average increase of 29.0% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.86% to 1.12% in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.0% return, outperforming this stock by 165.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 51.1% return, outperforming this stock by 74.9%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 54.67% to 54.45% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 44.45% to 44.42% in Mar 2025 quarter

About Kopran

Kopran, a pharmaceutical company controlled by Parijat Enterprises and promoted by Somani group, came out with a public issue in Nov.92 to finance its backward integration project and expand its antibiotic facility. Its bulk drug plant is approved by the US FDA and UK regulatory authorities, and in 1995 they were awarded Quality Excellence award by Indian Drug Manufacturers Association. Kopran manufactures penicillin and amoxycillin and has collaborations with Germany, South Korea, US and Adac Laboratories.They launched new products for therapeutic groups like asthma, cardiology, diabetes and lifestyle and obtained approval from European Directorate for Quality of Medicines and UK MHRA. Furthermore, they increased their installed capacity of liquids by 3.00 lakhs of liters and tablets/capsules by 270 croresNos during 2001. They also had tied up with EMerck for comarketing a new antiinflammatory drug in India and subsequently launched Cholestat Atorvastatin. Kopran has a high growth rate in exports and has been ranked amongst the top few fastest growing companies in IndiaORG Marg June 2000.

Revenue: ₹139.44Cr as on June 2024 (Q2 24)
Net Profit: ₹11.10Cr as on June 2024 (Q2 24)
Listing date: 01 Dec, 1994
Chairperson Name: Susheel Somani
OrganisationKopran
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Indian Mutual Funds that own Kopran

Check out the Mutual Funds with significant holdings in Kopran.

Futures and Options

View the latest movement in Kopran Futures & Options, including strike prices, expiry dates, and percentage changes.

FAQs

What is Kopran Ltd price today?

Kopran Ltd share price today stands at ₹196.36, Open: ₹202.7, Previous Close: ₹201.09, High: ₹204.89, Low: ₹194.11, 52 Week High: ₹369.7, 52 Week Low: ₹155.

How to Buy Kopran Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Kopran Ltd shares

What are today's traded volumes of Kopran Ltd?

Today's traded volume of Kopran Ltd(KOPRAN) is 1.82L.

What is today's market capitalisation of Kopran Ltd?

Today's market capitalisation of Kopran Ltd(KOPRAN) is ₹917.81 Cr.

What is the 52 Week High and Low Range of Kopran Ltd?

Kopran Ltd (KOPRAN)
Price
52 Week High
₹369.7
52 Week Low
₹155

How much percentage Kopran Ltd is down from its 52 Week High?

Kopran Ltd (KOPRAN) share price is ₹196.36. It is down -46.89% from its 52 Week High price of ₹369.7

How much percentage Kopran Ltd is up from its 52 Week low?

Kopran Ltd (KOPRAN) share price is ₹196.36. It is up 26.68% from its 52 Week Low price of ₹155